Independent buyer’s guide · August 29, 2026
From general AI bots to $500 testing memberships — here is how they stack up on accuracy, longitudinal tracking, privacy, and cost.
At a glance
The same seven questions asked of every approach. Cost figures are US list prices as published in August 2026.
| Criterion | General-purpose AI ChatGPT, Claude, Gemini | Longevity testing memberships Function Health, InsideTracker | Dedicated lab analyzers BloodSight Best for personal tracking |
|---|---|---|---|
| Primary goal |
General AI
A text answer
One question, one reply, no record kept
|
Testing memberships
Selling the panel
The draw, the breadth, and the review
|
BloodSight
Independent tracking
Interpreting the reports you already have
|
| Cost |
General AI
$0 – $20/mo
Free tier, or a general chat subscription
|
Testing memberships
$365 – $500+/year
Membership, plus per-panel fees beyond it
|
BloodSight
$67/year
$5.58/mo billed annually · no free tier
|
| Accuracy on a real PDF |
General AI
High error risk
Column drift and misplaced decimals
|
Testing memberships
Clinical grade
For the tests they ordered and ran
|
BloodSight
LOINC-verified
Source file kept so every value stays checkable
|
| Year-over-year tracking |
General AI
None
Chat context expires and the thread is gone
|
Testing memberships
Their panels only
Limited to tests bought through them
|
BloodSight
Unified timeline
Every laboratory on one interactive chart
|
| Privacy posture |
General AI
Trains on your chats
Consumer tiers, unless you opt out
|
Testing memberships
Vendor-controlled
Your results inform what they sell you next
|
BloodSight
Zero AI training
AES-256 at rest · TLS 1.3 in transit
|
| Conflict of interest |
General AI
None
A generic tool with nothing to sell you
|
Testing memberships
Structural
Revenue depends on selling you more tests
|
BloodSight
Fully independent
Sells no tests, no panels, no supplements
|
| Family profiles |
General AI
One shared thread
No separation between people’s results
|
Testing memberships
One per membership
Every person needs their own plan
|
BloodSight
Up to 10 profiles
Isolated records on the Max plan
|
Approach 1 · $0 – $20/mo
A general assistant will happily read an attached report, define terms, and answer follow-up questions in natural language. It is the fastest way to get a readable sentence out of a confusing line — and the weakest way to build a medical record you can still rely on in three years.
A lab report is a dense table, and general models read it as flowing text. The common failure is column drift: your result gets pulled from one column and the reference interval from the row above, or a decimal place moves. The answer still arrives in fluent, confident prose — which is exactly what makes the error hard to catch. Nothing in the conversation shows you which cell a number came from.
US reports print glucose and cholesterol in mg/dL; most of the world uses mmol/L. A general assistant has no biomarker registry to check against, so it can compare a value in one unit to a reference range in the other and announce a dramatic abnormality that does not exist. Unit handling has to be a property of the software, not something the model reasons out fresh each time.
On consumer ChatGPT plans — Free, Plus, and Pro — new conversations are used to improve OpenAI’s models by default; turning that off is a setting you have to find in Data Controls. Most people uploading a lab PDF have never opened that menu. API-tier access, which is how purpose-built software calls these models, is excluded from training by default.
Two months later the thread is gone, or long enough that the earlier files have fallen out of context. You cannot ask it to chart what your vitamin D did between 2022 and 2026, because it never held those four reports as structured, dated rows in the first place. Every conversation restarts from zero, and you re-upload everything to ask one comparative question.
Where a general assistant genuinely wins
It is unbeatable for a single definition. If you want to know what “MCHC” stands for or why a lab measures ferritin at all, paste that one line and you will get a good answer in seconds, for free. The failure mode is not the explanation — it is treating the explanation as a reading of your report, or expecting the conversation to still exist as a health record next year.
Approach 2 · $365 – $500+/year
These are testing programs with an analysis layer attached, not analyzers with testing attached. You are buying the blood draw, the panel breadth, and the clinician or algorithmic review. That is a real service — and an expensive way to solve the problem if the blood work you care about already exists.
None of this makes them bad products — if you need 100+ new tests ordered and drawn, they do a job no software can. The question to ask is narrower: when a company earns its revenue from selling tests and supplements, “this marker is suboptimal, here is what to take” is a conclusion the business model rewards. Compare their range definitions against the interval your own laboratory printed before you act on a flag.
Approach 3 · From $5.58/mo ($67/year)
Purpose-built software for the part after the blood draw: read the complete report, map every row to its LOINC code, keep the laboratory’s own reference interval attached, and put repeat markers on one timeline no matter which lab produced them.
No tests to sell you, no supplements to recommend, no affiliate revenue on either. The only reference interval shown is the one your laboratory used.
Every row is matched to its Logical Observation Identifiers Names and Codes entry, so the same marker merges across labs that spell it differently — and units are standardized rather than guessed.
Quest, Labcorp, a hospital system, and an at-home panel land on one dated timeline, each result keeping its own source and range.
Up to 10 separate profiles under one subscription, each with its own reports, trends, and sharing — not one shared thread.
Strength
100% independent analysis with no attempt to sell you vitamins or push expensive new testing. Strict LOINC validation, long-term trend charts, and isolated profiles for the whole family.
Best for
People who already have results from any clinic and want a clear, private, convenient tool for long-term health tracking — not another subscription that ends in a supplement cart.
It works on the file, not on an account, so the reports can come from anywhere you already download them: Labcorp, Quest, MyChart, a hospital system, or an at-home kit. Export the PDF while you still have the login — that access outlives neither a job change nor an insurance change.
What it deliberately does not do: order tests, provide clinician review, diagnose, or recommend treatment. Inspect the complete sample output rather than taking any of this on trust.
Decide
Pick the sentence that describes your actual problem. Most people need two of these, not one.
You have one specific question about one term on one report and you want an answer in the next thirty seconds. Paste the single line rather than the whole file, and treat the reply as a definition, not a reading of your results.
Nobody is currently ordering comprehensive blood work for you and the missing step is the draw itself. You are buying 100+ new tests and a review, and that is worth $365/year only if you actually needed the tests ordered.
You already have reports — from several labs, across several years, possibly for several people — and you want them read accurately, kept privately, and charted over time by software that has nothing to sell you afterwards.
Research note: competitor pricing and data-handling claims were checked against official vendor pages and OpenAI’s published data-usage documentation on August 29, 2026. Pricing, regional availability, and privacy defaults change — confirm the current terms before purchasing or uploading. BloodSight receives no compensation for any link on this page.
Direct answers on chatbot accuracy, medical data privacy, and where each approach stops.
Not reliably. While ChatGPT can explain medical terms, it frequently struggles with multi-column lab PDFs, confuses values with adjacent reference ranges, lacks LOINC unit normalization such as mg/dL versus mmol/L, and does not maintain structured multi-year trend charts. The characteristic failures are column drift — pairing your value with the wrong reference interval — and misplaced decimals, and both arrive in confident prose with no indication of which cell a number came from. It also has no biomarker registry to catch a mg/dL value being compared against an mmol/L range. Treat it as a glossary, not as a reading of your results.
Check the data controls before you upload anything. On consumer ChatGPT plans — Free, Plus, and Pro — conversations are used to improve OpenAI’s models by default, and opting out is a toggle in Settings → Data Controls that most people have never opened. Business, Enterprise, Edu, and API access are excluded from training by default. Policies differ by vendor and change, so verify the current terms of the specific service and plan you are using.
Some do, and that is the point worth noticing. When a product’s revenue comes from supplements or from selling you more testing, “this marker is suboptimal” is a conclusion it has a financial reason to reach — often by comparing your result against a narrower proprietary range than the one your laboratory printed. BloodSight sells neither tests nor supplements, so the only range it shows you is the one the laboratory used.
An analyzer works on blood work that already exists — it reads, explains, standardizes, and tracks the reports you already received. A testing membership sells you the blood draw: the panel, the phlebotomy, the clinician review, and a protocol. If your problem is “nobody is ordering these tests for me,” you need the membership. If your problem is “I have eight PDFs from four labs and no idea what changed,” you need the analyzer. They are complementary, not competing.
There is no free option that does the whole job well. A general chatbot will explain individual terms at no cost, but it does not standardize units, does not hold your history, and misreads multi-column PDFs. Downloading the original report from whichever laboratory ran it is free and authoritative, and worth doing regardless — but it gives you one network’s file, not an analysis across every lab you have used. Free covers definitions and storage; it does not cover interpretation or multi-year tracking.
They compare against different ranges. Some preserve the reference interval printed by the laboratory that ran the assay on its own instruments. Others apply narrower research-derived “optimal” ranges. The same value can therefore be in range on the original report and flagged as suboptimal in an app — the number did not change, the yardstick did.
No, and none should be treated as diagnostic. They explain, organize, classify, or recommend. A diagnosis requires a qualified professional who can weigh symptoms, examination findings, medications, history, and appropriate follow-up testing against the numbers.
BloodSight publishes this page and is one of the three approaches compared, so read it with that in mind. Competitor pricing and policy claims were checked against official vendor and OpenAI documentation on August 29, 2026. We do not use review scores or a single fabricated overall rating, because the three approaches do different jobs and cannot share one scale.
Your next report
Walk through BloodSight’s complete sample analysis, then compare it against the official product pages linked above.